DD Support Board and Research Team

[bar1080]

I've never bought an IPO and I've never owned a small biomed stock although Iovance has a market cap of >$2 million which isn't so tiny. I only buy stocks with caps exceeding $10 billion. Large stocks have much more ability to survive market downturns and bear markets.

IPO stocks tend to be highly promoted initially and prone to falling when the excitement cools. IMO many small biomeds are perpetual startups. Borderline scams.

Insiders tend to be in them for the huge salaries. and have little incentive to actually bring products to market. Hence, round after round of testing. Lately it seems investors have figured out the problems with biomeds as the sector has cooled way off.